Search

Author/Creator Pittaluga, S.

1. CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT. (17th June 2021)

Authors:
Collinge, B. J.; Hilton, L. K; Wong, J.; Ben‐Neriah, S.; Rushton, C. K.; Slack, G. W.; Farinha, P.; Cook, J. R.; Ott, G.; Rosenwald, A.; Campo, E.; Amador, C.; Greiner, T. C.; Raess, P. W.; Song, J. Y.; Inghirami, G.; Jaffe, E. S.; Weisenburger, D. D.; Chan, W. C.; Holte, H.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE. (October 2022)

Authors:
Salmeron-Villalobos, J.; Egan, C.; Borgmann, V.; Müller, I.; Gonzalez-Farre, B.; Ramis-Zaldivar, J.; Nann, D.; Balagué, O.; Lopez-Guerra, M.; Colomer, D.; Oschlies, I.; Klapper, W.; Glaser, S.; Ko, Y.; Bonzheim, I.; Siebert, R.; Fend, F.; Pittaluga, S.; Campo, E.; Salaverria, I.
Journal:
Leukemia research
Issue:
Volume 121(2022)Supplement
Page Start:
S32
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS. (12th June 2019)

Authors:
Melani, C.J.; Lakhotia, R.; Pittaluga, S.; Miljkovic, M.D.; Portell, C.A.; Farah, R.J.; Juanitez, A.M.; Chou, L.L.; Steinberg, S.M.; Jaffe, E.S.; Staudt, L.M.; Roschewski, M.J.; Wilson, W.H.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗